Skip to content

Drug interactions

Anagrelide + Milrinone

Severity: Major

Anagrelide and Milrinone: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs are PDE3 inhibitors, so combined use may enhance positive inotropic, chronotropic and vasodilatory effects. This increases the risk of tachycardia, arrhythmias, hypotension and fluid retention or heart failure complications.

What this interaction means in plain words

Anagrelide and Milrinone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Anagrelide belongs to Cardiovascular; Milrinone belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Additive phosphodiesterase 3 inhibition.

What to do

Avoid combined use where possible; if unavoidable, monitor ECG, blood pressure and heart rate closely and consider holding anagrelide during milrinone infusion.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Anagrelide and Milrinone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Anagrelide with Milrinone?

MediHelp rates the interaction as major. Anagrelide and Milrinone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs are PDE3 inhibitors, so combined use may enhance positive inotropic, chronotropic and vasodilatory effects. This increases the risk of tachycardia, arrhythmias, hypotension and fluid retention or heart failure complications.

How serious is the interaction between Anagrelide and Milrinone?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combined use where possible; if unavoidable, monitor ECG, blood pressure and heart rate closely and consider holding anagrelide during milrinone infusion.

What other medicines interact with Milrinone?

MediHelp also lists interactions of Milrinone with, for example, Cilostazol, Enoximone, Inamrinone. The full list is on the Milrinone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in